Our scientific publications in high-quality journals reflect the quality of the innovative research in Entasis’ laboratories.

Search by Program

Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP

Determination of MIC quality control ranges for the novel gyrase inhibitor, zoliflodacin

Journal of Clinical Microbiology (2019)

Barnes MD, Kumar V, Bethel CR, Moussa SH, O’Donnell J, Rutter JD, Good CE, Hujer KM, Hujer AM, Marshall SH, Kreiswirth BN, Richter SS, Rather PN, Jacobs MR, Papp-Wallace KM, van den Akker F, and Bonomo RA

Targeting multidrug-resistant Acinetobacter spp.: sulbactam and the diazabicyclooctenone β-lactamase inhibitor ETX2514 as a novel therapeutic agent

mBio (2019)

Iyer R, Moussa S, Tommasi R, and Miller A

Role of the Klebsiella pneumoniae TolC porin in antibiotic efflux

Research in Microbiology (2019)

Taylor SN, Marrazzo J, Batteiger BE, Hook EW, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, and Mueller J

Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea

New England Journal of Medicine (2018)

O' Donnell J, Lawrence K, Vishwanathan K, Hosagrahara V, and Mueller JP

Single-dose pharmacokinetics, excretion, and metabolism of zoliflodacin, a novel spiropyrimidinetrione antibiotic, in healthy volunteers

Antimicrobial Agents and Chemotherapy (2018)

Cristillo AD, Bristow CC, Torrone E, Dillon J, Kirkcaldy RD, Dong H, Grad YH, Nicholas RA, Rice PA, Lawrence K, Oldach D, Shafer WM, Zhou P, Wi TE, Morris SR, and Klausner JD

Antimicrobial resistance in Neisseria gonorrhoeae: proceedings of the STAR sexually transmitted infection-clinical trial group programmatic meeting

Sexually Transmitted Diseases (2019)

Rodvold KA, Gotfried MH, Isaacs RD, O'Donnell JP, and Stone E

Plasma and intrapulmonary concentrations of ETX2514 and sulbactam following intravenous administration of ETX2514SUL to healthy adult subjects

Antimicrobial Agents and Chemotherapy (2018)

Tommasi R, Iyer R, and Miller A

Antibacterial drug discovery: some assembly required

ACS Infectious Diseases (2018)

Iyer R, Moussa S, Durand-Réville T, Tommasi R, and Miller A

Acinetobacter baumannii OmpA is a selective antibiotic permeant porin

ACS Infectious Diseases (2018)